NFE2L2 and endothelial dysfunction: In the current study, we demonstrate that a potent activator of Nrf2, the synthetic compound dh404, improved endothelial dysfunction in a diabetic mouse model in vivo and attenuated oxidative stress and inflammatory markers in the setting of diabetes in vitro.